Facebook-f Twitter Linkedin-in
August 22, 2025
  1. Home
  2. Buyout

Category: Noden Pharma

Buyout Stanley Capital scores 151% IRR on its first-ever exit with Noden Pharma sale

Stanley Capital scores 151% IRR on its first-ever exit with Noden Pharma sale

European mid-market buyout investor Stanley Capital Partners has scored a big exit success with the sale of Noden Pharma after just two years in its portfolio. The post Stanley Capital scores 151% IRR on its

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies